Work

Long-Acting PrEP and U.S. HIV Elimination: Mathematical Analysis and Optimal Control

Year: 2026
Type: article
Abstract: The U.S. Ending the HIV Epidemic (EHE) initiative targets 3000 annual HIV infections by 2030. This study develops a seven-compartment transmission model distinguishing oral and long-acting pre-exposure prophylaxis (PrEP), with infection-stage dynamics informed by within-host viral modeling. The mathematical analysis establishes well-posedness, derives the control reproduction number and critical PrEP coverage, and provides sufficient conditions for global disease-free stability and forward bifurcation. Bayesian calibration to national surveillance and PrEP-use data (2017–2024) indicates that the control reproduction number declined from 2.28 to 1.97, while projected incidence approaches an endemic plateau. Under current conditions, annual infections are projected at 25,500 in 2030. Transitioning new PrEP initiations to long-acting formulations reduces this estimate to 20,200, outperforming doubled oral PrEP initiation (21,100) only if annual persistence reaches approximately 78%; its comparative advantage is driven primarily by improved persistence within the examined parameter ranges. Combining long-acting PrEP expansion with improved diagnosis and viral suppression reduces projected incidence to 11,800 and brings the control reproduction number below unity under baseline assumptions. Nevertheless, none of the examined scenarios achieve the 2030 EHE target. Optimal control analysis favors early intensification of long-acting PrEP initiation and testing. These findings highlight PrEP persistence and coordinated improvements in HIV care as essential determinants of sustained transmission reduction.
Source: Mathematics
Language: English
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236678073
FWCI:
Cites: 39
Cited by:
Related to: 10